LivingGLP1
Study S001696

HRS-7535-202 Follow-up Study: A Long-term Evaluation of Safety, Tolerability, and Efficacy in Obese Subjects (Open-label, Extension Trial)

Registration

Registration
NCT06671821
Study type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Phase
PHASE2
Masking
NONE
Status
COMPLETED
Enrollment
81
Start
2024-11-20
Primary completion
2025-08-15
Lead sponsor
Shandong Suncadia Medicine Co., Ltd.
Conditions
Chronic Weight Management
Interventions
DRUG:HRS-7535
Results posted
FALSE
Individual participant data sharing
UNDECIDED

Registered primary outcomes

  • Number of participants with Treatment-emergent Adverse Event(AE) [During the 32-week open-label extension treatment period]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.